multistrain probiotics and lactulose in the treatment of minimal hepatic encephalopathy
نویسندگان
چکیده
background: some evidence has shown benefits of probiotics in the management of minimal hepatic encephalopathy (mhe). we evaluated the efficacy of a multistrain probiotic compound, alone and in combination with lactulose, in the treatment of mhe. materials and methods: h is study has two parts. first, consecutive adult patients with mhe were randomized to receive lactulose (30–60 ml/day) + probiotic (200 million colony forming units of seven bacteria species/day) (gp-lpr) or lactulose + placebo (gpl). in second part, a non-randomized group of patients received probiotic alone (gp-pr). medication duration was for 2 weeks and patients were followed-up for another 8 weeks. improvement in mhe status was assessed by psychometric hepatic encephalopathy score (phes). development of overt encephalopathy, hospitalization, and death were considered as secondary outcomes. results: sixty patients (80% male, mean age 38.4 ± 9.6 years) completed the intervention. phes signi?cantly improved after medication in all the three groups (gp-lpr: ?3.8 ± 3.9 to ?1.6 ± 3.0; gp-l: ?4.8 ± 4.1 to ?1.6 ± 2.9; and gp-pr: ?4.9 ± 3.7 to ?2.1 ± 2.5, p < 0.001). after 8 weeks follow-up, improvement was maintained in gp-lpr and gp-pr, but there was deterioration in those who did not receive probiotics (gp-l: phes score reversed to ?4.8 ± 4.2). two patients (one each in gp-l and gp-pr) experienced overt encephalopathy. one patient was hospitalized due to worsening of ascites (gp-lpr) and one due to spontaneous bacterial peritonitis (gp-l). side effects were mild and not signi?cantly di?erent among the groups. conclusions: lactulose and probiotics are e?ective for the treatment of mhe; however, probiotics, but not lactulose, have long-term e?ects. more studies are required before suggesting probiotics for the standard treatment of mhe.
منابع مشابه
Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
INTRODUCTION Hepatic encephalopathy is challenging complication of liver dysfunction. Therapeutic treatment options for hepatic encephalopathy are currently limited and have appreciable risks and benefits associated with their use. Rifaximin is a novel anti microbiological agent with wide spectrum of activity that has shown promise as an alternative option for hepatic encephalopathy. AIMS AND...
متن کاملHepatic Encephalopathy; to Compare the Efficacy of Lactulose Alone and Lactulose with Rifaxamin in Patients of Hepatic Encephalopathy
.. Background: Hepatic encephalopathy is one of the fatal complications of liver cirrhosis in clinical setting. A number of drugs with varied response have been tried up till now. Objectives: To compare the efficacy of lactulsoe alone and in combination with rifaxamin in cases with hepatic encephalopathy. Study Design: Randomized control trail. Setting: Sheikh Zayed Hospital (SZH) Rahim Yar Kha...
متن کاملProbiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.
AIM The present study was conducted to investigate the influence on gastrointestinal flora, counts of bifidobacteria and Enterobacterceae in colon and pH value of gastrointestinal after lactulose and probiotic treatment on rat experimental minimal hepatic encephalopathy (MHE) induced by thioactamide (TAA). METHODS MHE was induced by intraperitoneal injection of TAA. 48 male MHE models were th...
متن کاملRandomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy.
BACKGROUND Hepatic encephalopathy (HE) is associated with poor prognosis and treatment of HE is primarily directed at the reduction of the blood ammonia levels. The study evaluated the efficacy and safety of albumin plus lactulose versus lactulose alone for treatment of overt HE. METHODS In prospective randomized controlled trial, 120 patients with overt HE were randomized in two groups: grou...
متن کاملClinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
OBJECTIVE To evaluate the clinical efficacy of lactulose in patients with minimal hepatic encephalopathy (MHE). METHODS Randomized controlled trials (RCTs) comparing lactulose with placebo or with no intervention in the management of MHE that were conducted from January 1990 to July 2011 were searched from MEDLINE, EMBASE, SCI, Cochrane Controlled Trials Register, and China Biological Medicin...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of research in medical sciencesجلد ۱۹، شماره ۸، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023